These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36633476)

  • 1. Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.
    Aby ES; Moafa G; Latt N; Sultan MT; Cacioppo PA; Kumar S; Chung RT; Bloom PP; Gustafson J; Daidone M; Reinus Z; Debes JD; Sandhu S; Sohal A; Khalid S; Roytman M; Catana AM; Wegermann K; Carr RM; Saiman Y; Kassab I; Chen VL; Rabiee A; Rosenberg C; Nguyen V; Gainey C; Zhou K; Chavin K; Lizaola-Mayo BC; Chascsa DM; Varelas L; Moghe A; Dhanasekaran R
    Hepatol Commun; 2023 Jan; 7(1):e8874. PubMed ID: 36633476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of COVID-19 in patients with autoimmune hepatitis: A population-based matched cohort study.
    Krishnan A; Patel RA; Hadi YB; Mukherjee D; Shabih S; Thakkar S; Singh S; Woreta TA; Alqahtani SA
    World J Hepatol; 2023 Jan; 15(1):68-78. PubMed ID: 36744163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study.
    Kim D; Adeniji N; Latt N; Kumar S; Bloom PP; Aby ES; Perumalswami P; Roytman M; Li M; Vogel AS; Catana AM; Wegermann K; Carr RM; Aloman C; Chen VL; Rabiee A; Sadowski B; Nguyen V; Dunn W; Chavin KD; Zhou K; Lizaola-Mayo B; Moghe A; Debes J; Lee TH; Branch AD; Viveiros K; Chan W; Chascsa DM; Kwo P; Dhanasekaran R
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1469-1479.e19. PubMed ID: 32950749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study.
    Satapathy SK; Roth NC; Kvasnovsky C; Hirsch JS; Trindade AJ; Molmenti E; Barish M; Hirschwerk D; Da BL; Bernstein D;
    Hepatol Int; 2021 Jun; 15(3):766-779. PubMed ID: 33826042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term outcomes of patients with chronic liver disease hospitalised with COVID-19.
    Grgurevic I; Lucijanić M; Pastrovic F; Barisic Jaman M; Tjesic Drinkovic I; Zelenika M; Milosevic M; Medic B; Kardum D; Bokun T; Luksic I; Piskac Zivkovic N; Keres T; Grabovac V; Persec J; Barsic B
    Intern Med J; 2022 Nov; 52(11):1891-1899. PubMed ID: 35555962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of severe disease and mortality of COVID-19 in patients with Budd-Chiari syndrome: A population-based matched cohort study.
    Krishnan A; Schneider CV; Schattenberg JM; Alqahtani SA
    Liver Int; 2023 May; 43(5):1141-1144. PubMed ID: 36825357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease.
    Liaquat H; Shupp B; Rollins S; Schneider Y; Matin A
    Sci Rep; 2021 Sep; 11(1):19245. PubMed ID: 34584170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mortality of hospitalized patients with COVID-19 and non-cirrhotic chronic liver disease: a retrospective multi-center study.
    Wu PJ; Feng IC; Lai CC; Ho CH; Kan WC; Sheu MJ; Kuo HT
    PeerJ; 2023; 11():e16582. PubMed ID: 38077441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
    Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
    Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.
    Hirode G; Saab S; Wong RJ
    JAMA Netw Open; 2020 Apr; 3(4):e201997. PubMed ID: 32239220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
    Marjot T; Moon AM; Cook JA; Abd-Elsalam S; Aloman C; Armstrong MJ; Pose E; Brenner EJ; Cargill T; Catana MA; Dhanasekaran R; Eshraghian A; García-Juárez I; Gill US; Jones PD; Kennedy J; Marshall A; Matthews C; Mells G; Mercer C; Perumalswami PV; Avitabile E; Qi X; Su F; Ufere NN; Wong YJ; Zheng MH; Barnes E; Barritt AS; Webb GJ
    J Hepatol; 2021 Mar; 74(3):567-577. PubMed ID: 33035628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy.
    Ranzenigo M; Ceccarelli D; Galli L; Bertoni C; Siribelli A; Messina E; Hasson H; Lolatto R; Castagna A; Uberti-Foppa C; Morsica G
    New Microbiol; 2023 Sep; 46(3):296-302. PubMed ID: 37747475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study.
    Riou M; Marcot C; Canuet M; Renaud-Picard B; Chatron E; Porzio M; Dégot T; Hirschi S; Metz-Favre C; Kassegne L; Ederle C; Khayath N; Labani A; Leyendecker P; De Blay F; Kessler R;
    Respir Med Res; 2021 May; 79():100801. PubMed ID: 33259989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study.
    Simon TG; Hagström H; Sharma R; Söderling J; Roelstraete B; Larsson E; Ludvigsson JF
    BMC Gastroenterol; 2021 Nov; 21(1):439. PubMed ID: 34814851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Chronic Liver Disease Caused by Viral Hepatitis, Hospitalisation for COVID-19 and Mortality.
    Aslam J; Qaisar F; Khaliq M; Khalid M; Sabeeh DE; Ali AY
    J Coll Physicians Surg Pak; 2023 Jun; 33(6):647-652. PubMed ID: 37300260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis.
    John BV; Deng Y; Scheinberg A; Mahmud N; Taddei TH; Kaplan D; Labrada M; Baracco G; Dahman B
    JAMA Intern Med; 2021 Oct; 181(10):1306-1314. PubMed ID: 34254978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study.
    Ai J; Wang J; Liu D; Xiang H; Guo Y; Lv J; Zhang Q; Li J; Zhang X; Li Q; Liang J; Guo X; Feng Y; Liu L; Zhang X; Qin W; Wang X; Rao W; Zhang Q; Tian Q; Zhang Y; Xie F; Jiang S; Yan Y; Qiu Y; Wu H; Hou Z; Zhang N; Zhang A; Ji J; Yang J; Huang J; Zhao Z; Gu Y; Bian L; Zhang Z; Zou S; Ji H; Ge G; Du X; Hou A; Zhu Y; Cong Q; Xu J; Zu H; Wang Y; Yan Z; Yan X; BianBa Y; Ci Q; Zhang L; Yang S; Gao X; Zhong L; He S; Liu C; Huang Y; Liu Y; Xu D; Zhu Q; Xu X; Lv M; Zhang W; Qi X
    Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1516-1524.e2. PubMed ID: 34942370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection.
    Guerra Veloz MF; Cordero Ruiz P; Ríos-Villegas MJ; Del Pino Bellido P; Bravo-Ferrer J; Galvés Cordero R; Cadena Herrera ML; Vías Parrado C; Bellido Muñoz F; Vega Rodríguez F; Caunedo Álvarez Á; Rodríguez-Baño J; Carmona Soria I
    Rev Esp Enferm Dig; 2021 Feb; 113(2):103-109. PubMed ID: 33393329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.